BMAL1 and prostate carcinoma: It has been reported that BMAL1, a key transcription factor in circadian rhythms, regulates the incidence and maintenance of tumor cells in several types of cancer, such as ovarian cancer, lymphocytic leukemia, and prostate cancer [16,17,18].